Stockscreener 앱 받기
30.05
1.21%
0.36
시간 외 거래:
30.10
0.05
+0.17%
Edgewise Therapeutics Inc 주식(EWTX)의 최신 뉴스
Inflation Data: What analysts say about Edgewise Therapeutics Inc stock2026 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
How (EWTX) Movements Inform Risk Allocation Models - Stock Traders Daily
Why Edgewise Therapeutics stock topped the market on Tuesday - MSN
Death Cross: Is Edgewise Therapeutics Inc being accumulated by smart money2026 Action & Verified Short-Term Plans - baoquankhu1.vn
Edgewise Therapeutics Inc (EWTX) Stock Price, Quote, News & History - Benzinga
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - The Globe and Mail
Why Edgewise Therapeutics Stock Topped the Market on Tuesday - The Motley Fool
JPMorgan Chase & Co. Raises Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $45.00 - MarketBeat
JPMorgan raises Edgewise Therapeutics price target on pipeline outlook By Investing.com - Investing.com Canada
Edgewise Therapeutics' (EWTX) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Is Edgewise Therapeutics Inc being accumulated by smart money2026 Action & Verified Short-Term Plans - baoquankhu1.vn
Insider Sell: Can Edgewise Therapeutics Inc reach all time highs this yearRate Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Assessing Edgewise Therapeutics (EWTX) Valuation After Encouraging Long Term MESA Study Results - Yahoo Finance
Granahan Investment Management Trims Edgewise Therapeutics Holdings - National Today
HighVista Strategies Boosts Edgewise Therapeutics Stake - National Today
Edgewise Therapeutics, Inc. $EWTX Shares Purchased by HighVista Strategies LLC - MarketBeat
First Light Asset Management Reduces Stake in Edgewise Therapeutics - National Today
Granahan Investment Management LLC Trims Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
First Light Asset Management LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Why Edgewise Therapeutics (EWTX) Is Up 6.4% After Long-Term Sevasemten Becker DataAnd What's Next - Yahoo Finance
Edgewise Therapeutics Talks Phase III Becker Readout, EDG-7500 HCM Data Due in Q2 at Conference - Yahoo Finance
Edgewise Therapeutics (EWTX) Is Up 6.4% After New Long-Term Becker Data On Sevasemten Trial - simplywall.st
A Look At Edgewise Therapeutics (EWTX) Valuation After Encouraging Long Term Sevasemten Becker Data - Sahm
Edgewise reports functional stability in Becker dystrophy trial - Investing.com Nigeria
Integral Health Asset Management Boosts Edgewise Therapeutics Stake - National Today
Integral Health Asset Management LLC Raises Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise’s New EDG-7500 Study Signals Broader Cardiovascular Ambitions - TipRanks
Edgewise Therapeutics Completes Key Renal Study for EDG-7500, Setting Up Next Steps for Investors - TipRanks
Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Edgewise Therapeutics (EWTX) - The Globe and Mail
MDA 2026: Biogen, Sarepta, Edgewise Address Muscle Disorders - BioSpace
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX), Integer Holdings (ITGR) and Edgewise Therapeutics (EWTX) - The Globe and Mail
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
EWTX: 7500 advances toward Phase III in HCM, with Becker data showing disease stabilization - TradingView
American Century Companies Inc. Buys 312,307 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise reports functional stability in Becker dystrophy trial By Investing.com - Investing.com Canada
Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up - Finviz
Raymond James reiterates Strong Buy on Edgewise Therapeutics stock after trial data - Investing.com Canada
Truist reiterates Edgewise Therapeutics stock rating on trial data - Investing.com India
Truist reiterates Edgewise Therapeutics stock rating on trial data By Investing.com - Investing.com India
Edgewise Announces Positive Long-Term Sevasemten Data Demonstrat - GuruFocus
Will Edgewise Therapeutics Inc stock recover after earningsPortfolio Return Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
EPS Watch: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2026 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Trading Systems Reacting to (EWTX) Volatility - Stock Traders Daily
Wedbush Keeps Their Buy Rating on Edgewise Therapeutics (EWTX) - The Globe and Mail
Vanguard Group Inc. Has $77.92 Million Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Aug PreEarnings: Is Edgewise Therapeutics Inc being accumulated by smart money2025 Valuation Update & Daily Stock Momentum Reports - baoquankhu1.vn
Edgewise Therapeutics, Inc. (EWTX) Stock Price, News, Quote & History - Yahoo Finance
Edgewise Therapeutics to Present at Leerink Global Healthcare Conference on March 11, 2026 - geneonline.com
1.20%
0.06%
자본화:
|
볼륨(24시간):